skip to main content


Title: Hypoxia‐enhanced adhesion of red blood cells in microscale flow
Abstract Objectives

The advancement of microfluidic technology has facilitated the simulation of physiological conditions of the microcirculation, such as oxygen tension, fluid flow, and shear stress in these devices. Here, we present a micro‐gas exchanger integrated with microfluidics to studyRBCadhesion under hypoxic flow conditions mimicking postcapillary venules.

Methods

We simulated a range of physiological conditions and exploredRBCadhesion to endothelial or subendothelial components (FNorLN). Blood samples were injected into microchannels at normoxic or hypoxic physiological flow conditions. Quantitative evaluation ofRBCadhesion was performed on 35 subjects with homozygousSCD.

Results

Significant heterogeneity inRBCadherence response to hypoxia was seen amongSCDpatients.RBCs from a HEA population showed a significantly greater increase in adhesion compared toRBCs from a HNA population, for bothFNandLN.

Conclusions

The approach presented here enabled the control of oxygen tension in blood during microscale flow and the quantification ofRBCadhesion in a cost‐efficient and patient‐specific manner. We identified a unique patient population in whichRBCs showed enhanced adhesion in hypoxia in vitro. Clinical correlates suggest a more severe clinical phenotype in this subgroup.

 
more » « less
Award ID(s):
1552782
NSF-PAR ID:
10027485
Author(s) / Creator(s):
 ;  ;  ;  ;  
Publisher / Repository:
Wiley-Blackwell
Date Published:
Journal Name:
Microcirculation
Volume:
24
Issue:
5
ISSN:
1073-9688
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. In contrast to an obsolete notion that erythrocytes, or red blood cells (RBCs), play a passive and minor role in haemostasis and thrombosis, over the past decades there has been increasing evidence thatRBCs have biologically and clinically important functions in blood clotting and its disorders. This review summarizes the main mechanisms that underlie the involvement ofRBCs in haemostasis and thrombosisin vivo, such as rheological effects on blood viscosity and platelet margination, aggregation and deformability ofRBCs; direct adhesion and indirect biochemical interactions with endothelial cells and platelets. The ability of stored and pathologically alteredRBCs to generate thrombin through exposure of phosphatidylserine has been emphasized. The procoagulant and prothrombotic potential ofRBC‐derived microparticles transfused with storedRBCs or formed in various pathological conditions associated with haemolysis has been described along with prothrombotic effects of free haemoglobin and haem. Binding of fibrinogen or fibrin toRBCs may influence their effects on fibrin network structure, clot mechanical properties and fibrinolytic resistance. Recent data on platelet‐driven clot contraction show thatRBCs compressed by platelets pulling on fibrin form a tightly packed array of polyhedral erythrocytes, or polyhedrocytes, which comprises a nearly impermeable barrier important for haemostasis and wound healing.RBCs may perform dual roles, both helping to stem bleeding but at the same time contributing to thrombosis in a variety of ways.

     
    more » « less
  2. Abstract

    Sickle cell disease (SCD) is a recessive genetic blood disorder exhibiting abnormal blood rheology. Polymerization of sickle hemoglobin, due to a point mutation in theβ‐globingene of hemoglobin, results in aberrantly adhesive and stiff red blood cells (RBCs). Hemolysis, abnormal RBC adhesion, and abnormal blood rheology together impair endothelial health in people with SCD, which leads to cumulative systemic complications. Here, we describe a microfluidic assay combined with a micro particle image velocimetry technique for the integrated in vitro assessment of whole blood viscosity (WBV) and RBC adhesion. We examined WBV and RBC adhesion to laminin (LN) in microscale flow in whole blood samples from 53 individuals with no hemoglobinopathies (HbAA, N = 10), hemoglobin SC disease (HbSC, N = 14), or homozygous SCD (HbSS, N = 29) with mean WBV of 4.50 cP, 4.08 cP, and 3.73 cP, respectively. We found that WBV correlated with RBC count and hematocrit in subjects with HbSC or HbSS. There was a significant inverse association between WBV and RBC adhesion under both normoxic and physiologically hypoxic (SpO2of 83%) tests, in which lower WBV associated with higher RBC adhesion to LN in subjects with HbSS. Low WBV has been found by others to associate with endothelial activation. Altered WBV and abnormal RBC adhesion may synergistically contribute to the endothelial damage and cumulative pathophysiology of SCD. These findings suggest that WBV and RBC adhesion may serve as clinically relevant biomarkers and endpoints in assessing emerging targeted and curative therapies in SCD.

     
    more » « less
  3. Abstract Objective

    To characterize ossified bone marrow blood vessels and confirm the presence of ossified particles (OSP) in humans and rodents.

    Methods

    Human bone marrow blood vessels were processed for scanning and transmission electron microscopy. Whole blood samples were collected from younger (26‐39 years; n = 6) and older (55‐63 years; n = 6) volunteers and male Fischer‐344 rats (1 month, n = 7; 6 months, n = 7; 12 months, n = 7; 18‐months, n = 6; 24 months, n = 8).OSPin the whole blood samples were sorted and imaged with microscopy to determine diameter, circularity, and solidity. Additionally, the chemical composition ofOSPwas determined via elemental analysis.

    Results

    SEMrevealed two types of ossified bone marrow blood vessels: that is, “transitioning” and “ossified.”OSPwere adhered to the surface of transitioning vessels and theoretically gain access to and circulate within the blood. The majority ofOSPwere ≤15 μm in diameter, but many were of sufficient size to serve as emboli (ie, >15 μm).OSPwere predominately oblong in shape and several had jagged tips and edges.

    Conclusions

    We introduce a novel, bone‐like blood particle that may be diagnostic of bone marrow blood vessel ossification. Further,OSPmay associate with several disease states (eg, atherosclerosis).

     
    more » « less
  4. Abstract Objective

    To characterize a cohort of patients withSCN8A‐related epilepsy and to perform analyses to identify correlations involving the acquisition of neurodevelopmental skills.

    Methods

    We analyzed patient data (n = 91) submitted to an online registry tailored to characteristics of children withSCN8Avariants. Participants provided information on the history of their child's seizures, medications, comorbidities, and developmental skills based on the DenverIIitems. Spearman rank tests were utilized to test for correlations among a variety of aspects of seizures, medications, and neurodevelopmental progression.

    Results

    The 91 participants carried 71 missense variants (41 newly reported) and three truncating variants. Ages at seizure onset ranged from birth to >12 months of age (mean ± SD = 5 months 21 days ± 7 months 14 days). Multiple seizure types with multimodal onset times and developmental delay were observed as general features of this cohort. We found a positive correlation between a developmental score based upon percentage of acquired skills and the age at seizure onset, current seizure freedom, and initial febrile seizures. Analyses of cohort subgroups revealed clear distinctions between patients who had a single reported variant inSCN8Aand those with an additional variant reported in a gene other thanSCN8A, as well as between patients with different patterns of regression before and at seizure onset.

    Significance

    This is the first study of anSCN8A patient cohort of this size and for which correlations between age at seizure onset and neurodevelopment were investigated. Our correlation studies suggest that variants of uncertain significance should be considered in assessing children withSCN8A‐related disorders. This study substantially improves the characterization of this patient population and our understanding of the neurodevelopmental effects associated with seizures forSCN8A patients, and provides a clinical context at initial presentation that may be prognostic for developmental outcome.

     
    more » « less
  5. Objective

    To obtain the comprehensive transcriptome profile of human citrulline‐specific B cells from patients with rheumatoid arthritis (RA).

    Methods

    Citrulline‐ and hemagglutinin‐specific B cells were sorted by flow cytometry using peptide–streptavidin conjugates from the peripheral blood ofRApatients and healthy individuals. The transcriptome profile of the sorted cells was obtained byRNA‐sequencing, and expression of key protein molecules was evaluated by aptamer‐basedSOMAscan assay and flow cytometry. The ability of these proteins to effect differentiation of osteoclasts and proliferation and migration of synoviocytes was examined by in vitro functional assays.

    Results

    Citrulline‐specific B cells, in comparison to citrulline‐negative B cells, from patients withRAdifferentially expressed the interleukin‐15 receptor α (IL‐15Rα) gene as well as genes related to protein citrullination and cyclicAMPsignaling. In analyses of an independent cohort of cyclic citrullinated peptide–seropositiveRApatients, the expression ofIL‐15Rα protein was enriched in citrulline‐specific B cells from the patients’ peripheral blood, and surprisingly, all B cells fromRApatients were capable of producing the epidermal growth factor ligand amphiregulin (AREG). Production ofAREGdirectly led to increased migration and proliferation of fibroblast‐like synoviocytes, and, in combination with anti–citrullinated protein antibodies, led to the increased differentiation of osteoclasts.

    Conclusion

    To the best of our knowledge, this is the first study to document the whole transcriptome profile of autoreactive B cells in any autoimmune disease. These data identify several genes and pathways that may be targeted by repurposing severalUSFood and Drug Administration–approved drugs, and could serve as the foundation for the comparative assessment of B cell profiles in other autoimmune diseases.

     
    more » « less